These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16648862)
21. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [TBL] [Abstract][Full Text] [Related]
22. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642 [TBL] [Abstract][Full Text] [Related]
23. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. Mhawech-Fauceglia P; Saxena R; Zhang S; Terracciano L; Sauter G; Chadhuri A; Herrmann FR; Penetrante R J Clin Pathol; 2007 Jun; 60(6):709-14. PubMed ID: 16837628 [TBL] [Abstract][Full Text] [Related]
24. Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins. Saito M; Tanaka S; Mori A; Toyoshima N; Irie T; Morioka M Int J Hematol; 2007 Jun; 85(5):421-5. PubMed ID: 17562619 [TBL] [Abstract][Full Text] [Related]
25. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas. Hansmann ML; Küppers R Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240 [TBL] [Abstract][Full Text] [Related]
26. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783 [TBL] [Abstract][Full Text] [Related]
27. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
28. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation. Gibson SE; Dong HY; Advani AS; Hsi ED Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681 [TBL] [Abstract][Full Text] [Related]
29. Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma. Khan MR; Ahmad A; Kayani N; Minhas K Asian Pac J Cancer Prev; 2018 Dec; 19(12):3463-3466. PubMed ID: 30583670 [TBL] [Abstract][Full Text] [Related]
30. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Peh SC; Kim LH; Poppema S Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464 [TBL] [Abstract][Full Text] [Related]
31. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases. Cool CD; Bitter MA Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726 [TBL] [Abstract][Full Text] [Related]
32. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma. Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776 [TBL] [Abstract][Full Text] [Related]
33. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap. Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472 [TBL] [Abstract][Full Text] [Related]
34. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker. Nasr MR; Rosenthal N; Syrbu S Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257 [TBL] [Abstract][Full Text] [Related]
35. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas. Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313 [TBL] [Abstract][Full Text] [Related]
36. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. Møller MB; Nielsen O; Pedersen NT Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214 [TBL] [Abstract][Full Text] [Related]
37. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822 [TBL] [Abstract][Full Text] [Related]
38. [Classical Hodgkin's lymphoma: biology and grey zones]. Gaulard P; Brousse N Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950 [TBL] [Abstract][Full Text] [Related]
39. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Carbone A; Cozzi M; Gloghini A; Pinto A Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932 [TBL] [Abstract][Full Text] [Related]
40. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. Wang T; Lasota J; Hanau CA; Miettinen M APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]